StockNews.com began coverage on shares of Biocept (NASDAQ:BIOC – Get Rating) in a research report sent to investors on Tuesday. The brokerage issued a hold rating on the medical research company’s stock. Separately, Brookline Capital Management cut Biocept from a buy rating to a hold rating in a report on Friday, January 6th. Biocept Stock […]
StockNews.com assumed coverage on shares of Biocept (NASDAQ:BIOC – Get Rating) in a report released on Monday. The firm issued a hold rating on the medical research company’s stock. Separately, Brookline Capital Management cut Biocept from a buy rating to a hold rating in a research note on Friday, January 6th. Biocept Stock Performance Shares […]
Biocept, Inc. (NASDAQ:BIOC – Get Rating) saw a large increase in short interest during the month of March. As of March 15th, there was short interest totalling 139,000 shares, an increase of 35.9% from the February 28th total of 102,300 shares. Based on an average daily trading volume, of 164,500 shares, the days-to-cover ratio is […]
StockNews.com initiated coverage on shares of Biocept (NASDAQ:BIOC – Get Rating) in a research report report published on Monday morning. The brokerage issued a hold rating on the medical research company’s stock. Separately, Brookline Capital Management cut shares of Biocept from a buy rating to a hold rating in a research note on Friday, January […]